LEU011

Leucid Bio · Phase 1 active Biologic Quality 0/100

At a glance

Generic name	LEU011
Sponsor	Leucid Bio
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LEU011 CI brief — competitive landscape report
LEU011 updates RSS · CI watch RSS
Leucid Bio portfolio CI